Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(1.24)
# 3,502
Out of 4,876 analysts
342
Total ratings
33.44%
Success rate
-15.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $50 | $39.78 | +25.69% | 4 | Jun 26, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $17.23 | -41.96% | 14 | Jun 25, 2025 | |
| LYEL Lyell Immunopharma | Maintains: Neutral | $1 → $10 | $9.12 | +9.65% | 13 | Jun 24, 2025 | |
| VERV Verve Therapeutics | Downgrades: Neutral | $14 | $11.26 | +19.95% | 7 | Jun 18, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $30 | $9.61 | +212.17% | 4 | Jun 16, 2025 | |
| TIL Instil Bio | Reiterates: Buy | $125 | $22.17 | +463.82% | 17 | Jun 5, 2025 | |
| AVTX Avalo Therapeutics | Assumes: Buy | $15 | $4.76 | +215.13% | 1 | Jun 2, 2025 | |
| BOLD Boundless Bio | Initiates: Buy | $5 | $1.07 | +367.29% | 1 | Jun 2, 2025 | |
| HALO Halozyme Therapeutics | Reiterates: Buy | $72 | $52.53 | +37.06% | 36 | May 29, 2025 | |
| KYTX Kyverna Therapeutics | Upgrades: Buy | $4 → $5 | $3.47 | +44.09% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.31 | +116.45% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $46.70 | +39.19% | 3 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $4.18 | +258.85% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $16.57 | +171.58% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $100 | $12.34 | +710.37% | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $3.30 | +324.24% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.12 | +41.51% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $33.48 | +124.01% | 37 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $11.46 | +249.04% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.36 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.59 | +340.25% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $1.15 | +160.87% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.57 | +252.36% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.52 | +1,640.81% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $9.83 | +205.19% | 19 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.90 | +154.24% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $44 | $21.32 | +106.38% | 13 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $11.63 | +286.93% | 5 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.41 | - | 12 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $1.56 | +39,102,464.10% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.00 | - | 4 | Jun 2, 2023 |
Ionis Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $50
Current: $39.78
Upside: +25.69%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $17.23
Upside: -41.96%
Lyell Immunopharma
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $9.12
Upside: +9.65%
Verve Therapeutics
Jun 18, 2025
Downgrades: Neutral
Price Target: $14
Current: $11.26
Upside: +19.95%
Intellia Therapeutics
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $9.61
Upside: +212.17%
Instil Bio
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $22.17
Upside: +463.82%
Avalo Therapeutics
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $4.76
Upside: +215.13%
Boundless Bio
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.07
Upside: +367.29%
Halozyme Therapeutics
May 29, 2025
Reiterates: Buy
Price Target: $72
Current: $52.53
Upside: +37.06%
Kyverna Therapeutics
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $3.47
Upside: +44.09%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $2.31
Upside: +116.45%
May 20, 2025
Reiterates: Buy
Price Target: $65
Current: $46.70
Upside: +39.19%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $4.18
Upside: +258.85%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $16.57
Upside: +171.58%
May 8, 2025
Maintains: Buy
Price Target: $115 → $100
Current: $12.34
Upside: +710.37%
Apr 30, 2025
Reiterates: Buy
Price Target: $14
Current: $3.30
Upside: +324.24%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.12
Upside: +41.51%
Apr 16, 2025
Reiterates: Buy
Price Target: $75
Current: $33.48
Upside: +124.01%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $11.46
Upside: +249.04%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.36
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.59
Upside: +340.25%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $1.15
Upside: +160.87%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.57
Upside: +252.36%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $0.52
Upside: +1,640.81%
Mar 31, 2025
Reiterates: Buy
Price Target: $30
Current: $9.83
Upside: +205.19%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.90
Upside: +154.24%
Feb 25, 2025
Reiterates: Buy
Price Target: $44
Current: $21.32
Upside: +106.38%
Feb 7, 2025
Reiterates: Buy
Price Target: $45
Current: $11.63
Upside: +286.93%
Dec 16, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.41
Upside: -
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $1.56
Upside: +39,102,464.10%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.00
Upside: -